Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:43 PM
Ignite Modification Date:
2025-12-24 @ 4:43 PM
NCT ID:
NCT05913466
Eligibility Criteria:
Inclusion Criteria:
* Patient with an age between 50 and 85 years old
* who had benign prostatic hyperplasia (aged 50-85 years) with a prostate weight of 50-80 g.
* undergoing Transurethral resection of the prostate
Exclusion Criteria:
* Patient refusal.
* Patients hypersensitive to Tranexamic Acid, or on antiplatelet and anticoagulant drugs.
* Patients with a history of thrombotic events, bleeding disorders, chronic kidney disease.
* Patients with abnormal liver function test.
* Patients with cardiovascular disease and receiving with a drug-eluting stent, bladder stone, urethral stricture, or with previous prostate surgery, prostate cancer, with a UTI or who receiving 5α-reductase inhibitors.
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
50 Years
Maximum Age:
85 Years
Study:
NCT05913466
Study Brief:
Protocol Section:
NCT05913466